An inhibitor of alpha glucosidase that retards the digestion and absorption of carbohydrates in the small intestine and hence reduces the increase in blood-glucose concentrations after a carbohydrate load.
It is given orally to non-insulin dependent precose generic name lyrica mellitus patients where diet modification or oral hypoglycemic agents do not control their condition. From Martindale The Extra Pharmacopoeia, 31st ed. For treatment and management of diabetes precose generic name lyrica II used in combination therapy as a second or third line agent.
Used to reduce blood gluose in patients with type 2 diabetes. Precose generic name lyrica is a complex oligosaccharide that delays the digestion of ingested carbohydrates, thereby resulting in a smaller rise precose generic name lyrica blood glucose concentration following meals. Acarbose precose generic name lyrica to and inhibits alpha amylase and alpha-gluocside hydrolases. In diabetic patients, this enzyme inhibition results in a delayed glucose absorption and a lowering of postprandial hyperglycemia.
Acarbose reversibly bind to pancreatic alpha-amylase and membrane-bound precose generic name lyrica alpha-glucoside hydrolases.
These enzymes inhibit precose generic name lyrica of complex starches to name lyrica in the lumen of the small intestine and hydrolysis of oligosaccharides, trisaccharides, and disaccharides to glucose and other monosaccharides in the brush border of the small intestine.
Peak precose generic name lyrica precose generic of the active drug were achieved 1 hour after dosing. Drug accumulation does not occur with multiple doses. Acarbose is only metabolized within the gastrointestinal tract by intestinal bacteria and also digestive enzymes to a lesser extent.
One metabolite formed by cleavage of precose generic name lyrica glucose molecule from acarbose also has alpha-glucosidase inhibitory activity. The fraction of acarbose precose generic name is here as intact drug is almost completely excreted by the kidneys.
Patent US, issued December, Drug created on June 13, Acarbose Targets 4 Biointeractions 4. Drug Interaction 2,4-thiazolidinedione The risk or severity of hypoglycemia can be increased when Acarbose is combined with 2,4-thiazolidinedione.
Abacavir Acarbose may decrease the excretion rate of Abacavir which could result in a higher serum level. Aceclofenac Aceclofenac may decrease the excretion rate of Acarbose which could precose generic name lyrica in a higher serum level.
Acemetacin Acemetacin may decrease the excretion rate of Acarbose name lyrica could result in a higher serum lyrica. Acetaminophen Acarbose may decrease the excretion rate of Acetaminophen name lyrica could result in a higher serum level.
Acetazolamide /colchicine-dosage-instructions-elderly.html this precose generic name lyrica page efficacy of Acarbose can be increased when used in combination with Acetazolamide.
Acetohexamide The risk or name lyrica of hypoglycemia can be increased when Acarbose is combined with Acetohexamide. Acetyl sulfisoxazole The therapeutic efficacy of Acarbose can be increased when used in name lyrica with Acetyl sulfisoxazole.
Acetylsalicylic acid Acetylsalicylic acid may increase the hypoglycemic activities of Acarbose. Aclidinium Acarbose may decrease the excretion rate precose generic Aclidinium precose generic name could lyrica in a higher serum level.
Acrivastine Acarbose precose generic name lyrica decrease the excretion rate of Acrivastine precose generic name lyrica could result in a higher serum level.
2018 ©